Host-parasite relationships in experimental airborne tuberculosis. I. Preliminary studies in BCG-vaccinated and nonvaccinated animals - PubMed (original) (raw)
Host-parasite relationships in experimental airborne tuberculosis. I. Preliminary studies in BCG-vaccinated and nonvaccinated animals
D W Smith et al. J Bacteriol. 1966 Feb.
Abstract
Smith, D. W. (University of Wisconsin, Madison), E. Wiegeshaus, R. Navalkar, and A. A. Grover. Host-parasite relationships in experimental airborne tuberculosis. I. Preliminary studies in BCG-vaccinated and nonvaccinated animals. J. Bacteriol. 91:718-724. 1966.-Previous studies from this laboratory on immunogenicity and allergenicity of defatted mycobacterial vaccines involved subcutaneous challenge of guinea pigs and killing of the animals 6 weeks later to evaluate the amount of disease. This type of experiment has discontinued in this laboratory in favor of an airborne challenge type of experiment, with the advantages that animals can be challenged with small numbers of bacilli by a natural route, and the number of primary lesions, the rate of spread from those lesions, and the rate of bacillary multiplication can be used to evaluate protection. Experiments to determine uniformity of infection showed that a fair degree of uniformity resulted when seven guinea pigs were exposed simultaneously, and were studied 3 weeks later to determine numbers of primary lesions and bacilli in the tissues. A less satisfactory degree of uniformity was obtained when more animals were exposed at one time. BCG-vaccinated and nonvaccinated animals were studied to determine the earliest time and the optimal time for killing the animals to detect the effects of vaccination. In guinea pigs, the degree of protection assessed by lesion counts is time-dependent, but the degree of protection assessed by viable counts of bacilli in the tissues was relatively constant 3 to 12 weeks after infection. Mice vaccinated subcutaneously with BCG were not protected against infection at any interval between 2 and 19 weeks. Guinea pigs vaccinated subcutaneously with the same lot of vaccine were protected as judged by counts of viable bacilli in the tissues 3 weeks after infection.
Similar articles
- Mycobacterium bovis BCG vaccine fails to protect protein-deficient guinea pigs against respiratory challenge with virulent Mycobacterium tuberculosis.
McMurray DN, Carlomagno MA, Mintzer CL, Tetzlaff CL. McMurray DN, et al. Infect Immun. 1985 Nov;50(2):555-9. doi: 10.1128/iai.50.2.555-559.1985. Infect Immun. 1985. PMID: 3932212 Free PMC article. - Cytokine profiles in primary and secondary pulmonary granulomas of Guinea pigs with tuberculosis.
Ly LH, Russell MI, McMurray DN. Ly LH, et al. Am J Respir Cell Mol Biol. 2008 Apr;38(4):455-62. doi: 10.1165/rcmb.2007-0326OC. Epub 2007 Nov 21. Am J Respir Cell Mol Biol. 2008. PMID: 18032570 Free PMC article. - Cellular and humoral immune responses to mycobacterial stress proteins in experimental pulmonary tuberculosis.
Bartow RA, McMurray DN. Bartow RA, et al. Tuber Lung Dis. 1997;78(3-4):185-93. doi: 10.1016/s0962-8479(97)90025-3. Tuber Lung Dis. 1997. PMID: 9713651 - [Novel vaccines against M. tuberculosis].
Okada M. Okada M. Kekkaku. 2006 Dec;81(12):745-51. Kekkaku. 2006. PMID: 17240920 Review. Japanese.
Cited by
- Host-parasite relationships in experimental airborne tuberculosis. II. Reproducible infection by means of an inoculum preserved at -70 C.
Grover AA, Kim HK, Wiegeshaus EH, Smith DW. Grover AA, et al. J Bacteriol. 1967 Oct;94(4):832-5. doi: 10.1128/jb.94.4.832-835.1967. J Bacteriol. 1967. PMID: 4964472 Free PMC article. - Why does drug resistance readily evolve but vaccine resistance does not?
Kennedy DA, Read AF. Kennedy DA, et al. Proc Biol Sci. 2017 Mar 29;284(1851):20162562. doi: 10.1098/rspb.2016.2562. Proc Biol Sci. 2017. PMID: 28356449 Free PMC article. Review. - Mycobacterium marinum down-regulates miR-148a in macrophages in an EsxA-dependent manner.
Wu H, Bao Y, Wang L, Li X, Sun J. Wu H, et al. Int Immunopharmacol. 2019 Aug;73:41-48. doi: 10.1016/j.intimp.2019.04.056. Epub 2019 May 9. Int Immunopharmacol. 2019. PMID: 31078924 Free PMC article. - Advancing Adjuvants for Mycobacterium tuberculosis Therapeutics.
Enriquez AB, Izzo A, Miller SM, Stewart EL, Mahon RN, Frank DJ, Evans JT, Rengarajan J, Triccas JA. Enriquez AB, et al. Front Immunol. 2021 Oct 25;12:740117. doi: 10.3389/fimmu.2021.740117. eCollection 2021. Front Immunol. 2021. PMID: 34759923 Free PMC article. Review. - Efficacy and Safety of BCG Vaccine for Control of Tuberculosis in Domestic Livestock and Wildlife.
Buddle BM, Vordermeier HM, Chambers MA, de Klerk-Lorist LM. Buddle BM, et al. Front Vet Sci. 2018 Oct 26;5:259. doi: 10.3389/fvets.2018.00259. eCollection 2018. Front Vet Sci. 2018. PMID: 30417002 Free PMC article. Review.
References
- Am Rev Respir Dis. 1959 Sep;80:340-58 - PubMed
- Am Rev Respir Dis. 1962 Jun;85:833-46 - PubMed
- Appl Microbiol. 1958 Jul;6(4):274-6 - PubMed
- Am Rev Tuberc. 1951 Oct;64(4):353-80 - PubMed
- J Bacteriol. 1964 Jul;88:87-92 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources